PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DENALI ADVISORS LLC | 265,730 | $2,572,000 | 0.70% |
| Global X Management CO LLC | 1,160,576 | $11,234,000 | 0.65% |
| Advisors Asset Management, Inc. | 4,727,365 | $45,761,000 | 0.63% |
| Spark Investment Management LLC | 436,800 | $4,219,000 | 0.63% |
| LINDEN ADVISORS LP | 183,836 | $1,780,000 | 0.39% |
| Blue Fin Capital, Inc. | 46,361 | $449,000 | 0.36% |
| Atria Investments, Inc | 356,359 | $3,450,000 | 0.34% |
| QS Investors, LLC | 1,326,900 | $12,844,000 | 0.34% |
| BURNEY CO/ | 392,470 | $3,799,000 | 0.33% |
| Calvert Investment Management, Inc. | 506,662 | $4,904,000 | 0.33% |